Structures by: Abdullah Z.
Total: 71
Alstolucine B
C20H22N2O3
Journal of natural products (2010) 73, 11 1891-1897
a=7.80370(10)Å b=11.7086(2)Å c=18.3534(3)Å
α=90.00° β=90.00° γ=90.00°
Scholaricine
2(C20H24N2O4),C4H8O2,H2O
Journal of natural products (2010) 73, 11 1891-1897
a=10.4901(3)Å b=18.5736(5)Å c=21.1075(5)Å
α=90.00° β=90.00° γ=90.00°
Phenyl quinoxalin-2-yl ether
C14H10N2O
Acta Crystallographica Section E (2008) 64, 11 o2165
a=7.9447(2)Å b=6.51690(10)Å c=20.2992(5)Å
α=90.00° β=91.9830(10)° γ=90.00°
2-(4-Chloroanilino)pyridine
C11H9ClN2
Acta Crystallographica Section E (2008) 64, 9 o1800
a=7.3926(3)Å b=15.3577(5)Å c=17.6093(6)Å
α=73.723(2)° β=87.360(3)° γ=87.128(3)°
Phenyl quinoxalin-2-yl ether
C14H10N2O
Acta Crystallographica Section E (2008) 64, 9 o1820
a=18.175(2)Å b=6.6589(8)Å c=19.488(2)Å
α=90° β=112.937(2)° γ=90°
Quinoxalin-2-yl <i>m</i>-tolyl ether
C15H12N2O
Acta Crystallographica Section E (2008) 64, 9 o1822
a=18.5958(5)Å b=7.07100(10)Å c=19.4821(5)Å
α=90.00° β=112.4870(10)° γ=90.00°
Quinoxalin-2-yl <i>p</i>-tolyl ether
C15H12N2O
Acta Crystallographica Section E (2008) 64, 9 o1823
a=5.26550(10)Å b=9.1713(2)Å c=12.8112(2)Å
α=74.6600(10)° β=81.1630(10)° γ=89.0950(10)°
Quinoxalin-2-yl <i>o</i>-tolyl ether
C15H12N2O
Acta Crystallographica Section E (2008) 64, 9 o1821
a=7.874(2)Å b=7.4130(10)Å c=10.596(2)Å
α=90.00° β=108.332(3)° γ=90.00°
N-(pyrazin-2-yl)aniline
C10H9N3
Acta Crystallographica Section E (2008) 64, 11 o2106
a=8.2194(3)Å b=8.8851(3)Å c=11.8395(4)Å
α=90.00° β=104.643(2)° γ=90.00°
N-(pyrazin-2-yl)aniline
C10H9N3
Acta Crystallographica Section E (2008) 64, 11 o2105
a=11.0644(3)Å b=7.8423(3)Å c=10.8907(3)Å
α=90.00° β=116.439(2)° γ=90.00°
1-Naphthyl quinoxalin-2-yl ether
C18H12N2O
Acta Crystallographica Section E (2009) 65, 4 o731
a=18.2758(6)Å b=18.5123(6)Å c=7.7947(3)Å
α=90° β=90° γ=90°
2-Naphthyl quinoxalin-2-yl ether
C18H12N2O
Acta Crystallographica Section E (2009) 65, 4 o732
a=6.8080(10)Å b=7.6090(10)Å c=26.234(3)Å
α=90° β=92.522(2)° γ=90°
<i>N</i>-(Pyrimidin-2-yl)aniline
C10H9N3
Acta Crystallographica Section E (2009) 65, 4 o703
a=8.8792(2)Å b=9.9382(2)Å c=10.2038(2)Å
α=93.1860(10)° β=103.6650(10)° γ=97.7800(10)°
2-(4-Chloroanilino)quinoxaline
C14H10ClN3
Acta Crystallographica Section E (2008) 64, 12 o2443
a=12.1550(10)Å b=11.2380(10)Å c=35.421(3)Å
α=90.00° β=90.00° γ=90.00°
4-Chloro-<i>N</i>-(2-pyridyl)aniline
C11H9ClN2
Acta Crystallographica Section E (2008) 64, 12 o2437
a=15.5096(4)Å b=7.5519(2)Å c=17.6846(4)Å
α=90.00° β=106.284(2)° γ=90.00°
<i>N</i>-(3-Methylphenyl)pyrimidin-2-amine
C11H11N3
Acta Crystallographica Section E (2010) 66, 9 o2446
a=9.4461(10)Å b=10.0946(11)Å c=11.6266(13)Å
α=80.4010(10)° β=82.745(2)° γ=66.0050(10)°
Phenyl pyrazin-2-yl ether
C10H8N2O
Acta Crystallographica Section E (2009) 65, 1 o7
a=5.7040(10)Å b=8.557(2)Å c=17.595(4)Å
α=90.00° β=94.382(3)° γ=90.00°
2-(Pyrimidin-2-yloxy)phenol
C10H8N2O2
Acta Crystallographica Section E (2010) 66, 9 o2212
a=18.0849(18)Å b=7.3293(8)Å c=13.3983(14)Å
α=90° β=92.5210(10)° γ=90°
2-(4-Methoxyphenoxy)pyrazine
C11H10N2O2
Acta Crystallographica Section E (2010) 66, 9 o2303
a=5.8783(2)Å b=10.9298(4)Å c=15.6430(6)Å
α=90° β=97.109(2)° γ=90°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[4-methyl-<i>N</i>-(4- methylphenyl)pyridin-2-amine-κ<i>N</i>^1^]copper(II)}
C34H40Cu2N4O8
Acta Crystallographica Section E (2010) 66, 9 m1077-m1078
a=11.7519(6)Å b=15.5822(8)Å c=9.9050(5)Å
α=90° β=110.5698(6)° γ=90°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[<i>N</i>-(4-chlorophenyl)-4- methylpyridin-2-amine-κ<i>N</i>^1^]copper(II)}
C32H34Cl2Cu2N4O8
Acta Crystallographica Section E (2010) 66, 9 m1049-m1050
a=11.7430(17)Å b=15.619(2)Å c=9.9866(14)Å
α=90° β=109.901(2)° γ=90°
<i>N</i>-(Pyrazin-2-yl)-4-toluidine
C11H11N3
Acta Crystallographica Section E (2008) 64, 12 o2440
a=21.7179(7)Å b=7.5323(3)Å c=12.0073(5)Å
α=90.00° β=105.790(3)° γ=90.00°
<i>N</i>-(2-Pyridyl)-4-toluidine
C12H12N2
Acta Crystallographica Section E (2008) 64, 12 o2441
a=18.2260(7)Å b=10.5680(3)Å c=10.6005(3)Å
α=90.00° β=95.364(2)° γ=90.00°
4-Chloro-<i>N</i>-(pyrazin-2-yl)aniline
C10H8ClN3
Acta Crystallographica Section E (2009) 65, 1 o113
a=12.1257(3)Å b=3.79440(10)Å c=19.7242(5)Å
α=90.00° β=91.370(2)° γ=90.00°
4-Chloro-<i>N</i>-(pyrimidin-2-yl)aniline
C10H8ClN3
Acta Crystallographica Section E (2009) 65, 1 o94
a=3.77500(10)Å b=10.0589(3)Å c=12.0116(3)Å
α=89.2370(10)° β=89.0370(10)° γ=89.399(2)°
<i>N</i>-(Quinoxalin-2-yl)-4-toluidine
C15H13N3
Acta Crystallographica Section E (2009) 65, 1 o93
a=12.2081(9)Å b=11.3720(9)Å c=35.097(3)Å
α=90.00° β=90.00° γ=90.00°
2-Phenoxypyrimidine
C10H8N2O
Acta Crystallographica Section E (2009) 65, 1 o114
a=10.8590(10)Å b=20.181(2)Å c=8.1339(8)Å
α=90° β=106.637(2)° γ=90°
3-Nitrophenyl pyrimidin-2-yl ether
C10H7N3O3
Acta Crystallographica Section E (2009) 65, 4 o704
a=18.1360(3)Å b=7.33550(10)Å c=14.5986(3)Å
α=90.00° β=90.00° γ=90.00°
1<i>H</i>-Benzimidazol-2-ylmethyl phenyl ether
C14H12N2O
Acta Crystallographica Section E (2009) 65, 4 o733
a=10.0299(5)Å b=8.5391(4)Å c=27.0000(10)Å
α=90.00° β=90.00° γ=90.00°
2-(3-Chloroanilino)pyridine
C11H9ClN2
Acta Crystallographica Section E (2009) 65, 6 o1449
a=3.89540(10)Å b=10.7804(4)Å c=12.4548(4)Å
α=64.932(2)° β=88.004(2)° γ=88.240(2)°
4-Amino-2-phenoxypyrimidine
C10H9N3O
Acta Crystallographica Section E (2009) 65, 8 o1858
a=8.8443(3)Å b=12.1214(3)Å c=9.0415(2)Å
α=90.00° β=96.751(2)° γ=90.00°
2-(<i>o</i>-Tolyloxy)pyrimidine
C11H10N2O
Acta Crystallographica Section E (2009) 65, 8 o1859
a=11.2918(2)Å b=7.22750(10)Å c=23.3359(5)Å
α=90.00° β=90.00° γ=90.00°
2-(2-Naphthyloxy)pyrimidine
C14H10N2O
Acta Crystallographica Section E (2009) 65, 8 o1881
a=13.0119(3)Å b=22.4944(5)Å c=7.5355(2)Å
α=90.00° β=90.00° γ=90.00°
2-(<i>o</i>-Tolyloxy)pyrimidine
C11H10N2O
Acta Crystallographica Section E (2009) 65, 8 o1880
a=7.5197(2)Å b=12.7997(3)Å c=20.3238(4)Å
α=90.00° β=90.00° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[2-(<i>m</i>-tolylamino)pyridine- κ<i>N</i>]copper(II)}
C32H36Cu2N4O8
Acta Crystallographica Section E (2009) 65, 12 m1690
a=7.7143(2)Å b=10.5625(3)Å c=11.2413(3)Å
α=66.531(2)° β=85.740(2)° γ=78.568(2)°
<i>N</i>-(4-Methyl-2-pyridyl)-<i>p</i>-toluidine
C13H14N2
Acta Crystallographica Section E (2010) 66, 2 o371
a=10.9385(11)Å b=7.5708(8)Å c=13.4372(14)Å
α=90.00° β=95.246(2)° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[4-methyl-2-(<i>m</i>- tolylamino)pyridine-κ<i>N</i>]copper(II)}
C34H40Cu2N4O8
Acta Crystallographica Section E (2010) 66, 2 m165
a=8.2489(4)Å b=14.2110(7)Å c=16.4484(8)Å
α=107.7980(10)° β=101.9710(10)° γ=97.6610(10)°
<i>N</i>-(4-Chlorophenyl)-4-methylpyridin-2-amine
C12H11ClN2
Acta Crystallographica Section E (2010) 66, 8 o2186
a=15.9335(15)Å b=4.0651(4)Å c=17.0153(16)Å
α=90° β=98.7550(10)° γ=90°
2-(3-Methoxyphenoxy)pyrimidine
C11H10N2O2
Acta Crystallographica Section E (2010) 66, 8 o2187
a=8.8120(16)Å b=18.215(3)Å c=7.2094(10)Å
α=90° β=119.380(2)° γ=90°
2-(4-Methoxyphenoxy)-3-nitropyridine
C12H10N2O4
Acta Crystallographica Section E (2010) 66, 9 o2428
a=7.4737(10)Å b=12.8128(17)Å c=24.529(3)Å
α=90° β=90° γ=90°
2-(3-Nitrophenoxy)quinoxaline
C14H9N3O3
Acta Crystallographica Section E (2010) 66, 9 o2429
a=6.0643(6)Å b=5.3676(5)Å c=18.2443(17)Å
α=90° β=91.7800(10)° γ=90°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis[(<i>N</i>-ethylpyrimidin-2- amine)copper(II)](<i>Cu</i>—–-<i>Cu</i>)
C20H30Cu2N6O8
Acta Crystallographica Section E (2010) 66, 9 m1181
a=7.8488(6)Å b=8.5114(7)Å c=10.2999(8)Å
α=98.4040(10)° β=92.6980(10)° γ=105.5990(10)°
<i>N</i>-(4-Methylphenyl)-3-nitropyridin-2-amine
C12H11N3O2
Acta Crystallographica Section E (2010) 66, 9 o2400
a=10.6557(12)Å b=7.1415(8)Å c=27.958(3)Å
α=90° β=91.310(2)° γ=90°
1-Tosyl-2-[(1-tosyl-1<i>H</i>-benzimidazol-2-yl)methylsulfanyl]-1<i>H</i>- benzimidazole
C29H24N4O4S3
Acta Crystallographica Section E (2011) 67, 5 o1043
a=8.2524(6)Å b=13.5905(10)Å c=13.8117(10)Å
α=62.5191(8)° β=75.4090(9)° γ=85.9930(9)°
5-nitro-2-(p-tolyloxy)pyridine
C12H10N2O3
Acta Crystallographica Section E (2011) 67, 11 o3077
a=7.2818(18)Å b=11.977(2)Å c=25.362(5)Å
α=90.00° β=90.00° γ=90.00°
N-(4-Methyl-2-pyridyl)-m-toluidine
C13H14N2
Acta Crystallographica Section E (2011) 67, 11 o3078
a=7.1802(9)Å b=7.6509(10)Å c=10.8120(14)Å
α=106.957(2)° β=91.859(2)° γ=95.720(2)°
2-(2-Methoxyphenoxy)pyrazine
C11H10N2O2
Acta Crystallographica Section E (2011) 67, 11 o3088
a=7.7497(10)Å b=5.8826(8)Å c=21.845(3)Å
α=90.00° β=92.459(2)° γ=90.00°
<i>N</i>-(3-Chlorophenyl)-3-nitropyridin-2-amine
C11H8ClN3O2
Acta Crystallographica Section E (2011) 67, 11 o3076
a=15.8781(10)Å b=3.7157(2)Å c=18.0651(13)Å
α=90.00° β=102.252(6)° γ=90.00°
2-(napthalen-2-yloxy)-5-nitropyridine
C15H10N2O3
Acta Crystallographica Section E (2011) 67, 11 o3079
a=6.7389(12)Å b=8.9182(16)Å c=21.072(4)Å
α=90.00° β=94.289(3)° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis{[<i>N</i>-(4- methylphenyl)pyridin-2-amine-κ<i>N</i>^1^]copper(II)}(<i>Cu</i>—–-<i>Cu</i>)
C32H36Cu2N4O8
Acta Crystallographica Section E (2011) 67, 11 m1636
a=7.6285(9)Å b=11.3242(13)Å c=18.566(2)Å
α=90.00° β=95.717(2)° γ=90.00°
Tetra-μ-acetato-κ^8^<i>O</i>:<i>O</i>-bis[(2- phenoxypyrimidine-κ<i>N</i>^1^)copper(II)](<i>Cu</i>—–-<i>Cu</i>)
C28H28Cu2N4O10
Acta Crystallographica Section E (2011) 67, 11 m1637
a=11.0738(9)Å b=7.5002(6)Å c=18.0539(14)Å
α=90.00° β=100.5790(10)° γ=90.00°
1,1'-{2,2'-[1,4-Phenylenebis(methylene)]bis(oxy)bis(2,1-phenylene)}diethanone
C24H22O4
Acta Crystallographica Section E (2011) 67, 11 o3016
a=6.84900(10)Å b=15.0815(2)Å c=17.8519(3)Å
α=90.00° β=90.00° γ=90.00°
Imidazo[1,2-<i>b</i>]isoquinoline-5,10-dione
C11H6N2O2
Acta Crystallographica Section E (2011) 67, 7 o1666
a=7.6518(7)Å b=7.2469(6)Å c=15.5197(13)Å
α=90.00° β=99.9470(10)° γ=90.00°
3-(2-Aminophenylsulfanyl)-1,3-diphenylpropan-1-one
C21H19NOS
Acta Crystallographica Section E (2011) 67, 7 o1693
a=11.1741(16)Å b=5.6788(8)Å c=27.308(4)Å
α=90.00° β=95.266(2)° γ=90.00°
4-(4-Hydroxymethyl-1<i>H</i>-1,2,3-triazol-1-yl)benzoic acid
C10H9N3O3
Acta Crystallographica Section E (2011) 67, 7 o1658
a=5.4641(7)Å b=6.6596(8)Å c=13.1898(16)Å
α=88.828(2)° β=83.577(2)° γ=75.828(2)°
2-Methyl-3-[(4-methylphenyl)sulfonyloxy]-2-{[(4- methylphenyl)sulfonyloxy]methyl}propyl 4-methylbenzenesulfonate
C26H30O9S3
Acta Crystallographica Section E (2011) 67, 7 o1838
a=10.2055(3)Å b=12.4029(3)Å c=12.7993(4)Å
α=66.868(2)° β=78.370(2)° γ=68.085(2)°
1,4-Diazabicyclo[2.2.2]octan-1-ium 4-nitrobenzoate dihydrate
C6H13N2,C7H4NO4,2(H2O)
Acta Crystallographica Section E (2014) 70, 7 31-35
a=6.59820(10)Å b=6.60740(10)Å c=34.4574(6)Å
α=90.00° β=94.8090(10)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane-1,4-diium bis(4-nitrobenzoate)
C6H14N22,2(C7H4NO4)
Acta Crystallographica Section E (2014) 70, 7 31-35
a=9.1036(4)Å b=9.5027(3)Å c=12.0736(3)Å
α=73.982(3)° β=83.624(3)° γ=88.661(3)°
<i>N</i>-(4-methylphenyl)-3-nitropyridin-2-amine
C12H11N3O2
Acta Crystallographica Section E (2014) 70, 8 58-61
a=11.4079(6)Å b=13.1968(8)Å c=14.3681(7)Å
α=90.00° β=96.387(5)° γ=90.00°
4-Nitrobenzoic acid--<i>N</i>-(pyrimidin-2-yl)aniline (1/1)
C10H9N3,C7H5NO4
Acta Crystallographica Section E (2011) 67, 11 o3080-o3081
a=12.7754(4)Å b=25.7788(8)Å c=9.5813(3)Å
α=90.00° β=104.209(4)° γ=90.00°
<i>tert</i>-Butyl 2-(1<i>H</i>-benzimidazol-1-yl)acetate
C13H16N2O2
Acta Crystallographica Section E (2012) 68, 3 o571
a=5.4204(2)Å b=11.3319(4)Å c=19.8771(7)Å
α=90.00° β=96.609(3)° γ=90.00°
<i>N</i>,<i>N</i>'-{[Ethane-1,2-diylbis(oxy)]bis(ethane-2,1-diyl)}bis(4- methylbenzenesulfonamide)
C20H28N2O6S2
Acta Crystallographica Section E (2012) 68, 7 o1983
a=11.135(7)Å b=9.220(6)Å c=21.452(15)Å
α=90.00° β=93.680(12)° γ=90.00°
1-Carboxymethyl-3-octylimidazolium bromide
C13H23N2O2,Br
Acta Crystallographica Section E (2011) 67, 7 o1701
a=7.6745(2)Å b=4.61760(10)Å c=41.8663(9)Å
α=90.00° β=92.1670(10)° γ=90.00°
2-(2-Methoxyphenoxy)-3-nitropyridine
C12H10N2O4
Acta Crystallographica Section E (2011) 67, 12 o3174
a=7.5017(7)Å b=7.1542(6)Å c=20.6369(18)Å
α=90.00° β=91.8780(10)° γ=90.00°
<i>N</i>-(4-Chlorophenyl)quinolin-2-amine
C15H11ClN2
Acta Crystallographica Section E (2011) 67, 12 o3175
a=5.9565(4)Å b=7.9936(6)Å c=25.0603(18)Å
α=90.00° β=92.7440(10)° γ=90.00°
N-(4-Chlorphenyl)-3-nitropyridine-2-amine
C11H8ClN3O2
Acta Crystallographica Section E (2011) 67, 12 o3176
a=30.472(3)Å b=3.8032(4)Å c=21.300(2)Å
α=90.00° β=123.1530(10)° γ=90.00°
1,1'-{[1,4-Phenylenebis(methylene)]bis(oxy)bis(3,1-phenylene)}diethanone
C24H22O4
Acta Crystallographica Section E (2011) 67, 12 o3140
a=20.6446(9)Å b=7.0205(4)Å c=6.5523(3)Å
α=90.00° β=93.083(3)° γ=90.00°
1,1'-{[1,4-Phenylenebis(methylene)]bis(oxy)bis(4,1-phenylene)}diethanone
C24H22O4
Acta Crystallographica Section E (2011) 67, 12 o3164
a=8.1286(12)Å b=8.1610(7)Å c=8.4878(6)Å
α=116.164(5)° β=106.328(7)° γ=100.196(7)°
<i>tert</i>-Butyl 2-(1<i>H</i>-imidazol-1-yl)acetate
C9H14N2O2
Acta Crystallographica Section E (2012) 68, 2 o445
a=10.558(2)Å b=9.287(2)Å c=11.047(2)Å
α=90.00° β=117.157(4)° γ=90.00°
1-Methyl-3-phenylimidazolidine-2-thione
C10H12N2S
Acta Crystallographica Section E (2014) 70, 3 o334
a=7.51590(10)Å b=14.0478(3)Å c=18.2050(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(3-Methylphenyl)quinoxalin-2-amine monohydrate
C15H13N3,H2O
Acta Crystallographica Section E (2010) 66, 9 o2276
a=10.9002(8)Å b=11.1048(8)Å c=11.1715(8)Å
α=90° β=106.7800(10)° γ=90°